ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.80
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      62,839.72
      -1.41%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BioXcel Therapeutics Inc (BTAI)

      7. BioXcel Therapeutics Inc (BTAI) News

      BTAI BioXcel Therapeutics Inc

      2.62
      0.01 (0.38%)
      Apr 26 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      BioXcel Therapeutics Inc BTAI NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.01 0.38% 2.62 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      2.61 2.52 2.65 2.63 2.61
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/202407:00GLOBEBioXcel Therapeutics to Report First Quarter 2024 Financial..
      4/24/202410:30GLOBEBioXcel Therapeutics Announces Late-Breaking Abstract on..
      4/22/202407:00GLOBEBioXcel Therapeutics Announces Plan for Evaluating BXCL501..
      4/10/202407:00GLOBEBioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal..
      3/25/202407:00GLOBEBioXcel Therapeutics Announces $25 Million Registered Direct..
      3/15/202407:00GLOBEBioXcel Therapeutics Announces European Patent Office’s..
      3/12/202407:00GLOBEBioXcel Therapeutics Reports Financial Results for the..
      3/01/202407:00GLOBEBioXcel Therapeutics to Report Fourth Quarter and Full Year..
      2/14/202407:00EDGAR2Form 8-K - Current report
      2/13/202409:00GLOBEBioXcel Therapeutics Announces Termination of Proposed..
      2/12/202412:45EDGAR2Form 8-K - Current report
      2/12/202407:14GLOBEBioXcel Therapeutics Receives FDA Fast Track Designation for..
      2/08/202417:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      2/08/202416:53EDGAR2Form 8-K - Current report
      2/08/202416:01GLOBEBioXcel Therapeutics Announces Proposed Public Offering
      2/08/202407:08EDGAR2Form 8-K - Current report
      2/06/202407:00GLOBEBioXcel Therapeutics Announces Completion of Patient..
      2/05/202407:00GLOBEBioXcel Therapeutics Announces USPTO’s Allowance of Patent..
      1/23/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
      1/12/202416:16EDGAR2Form S-3 - Registration statement under Securities Act of..
      12/18/202316:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202316:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/18/202307:22EDGAR2Form 8-K - Current report
      12/12/202307:00EDGAR2Form 8-K - Current report
      12/12/202307:00GLOBEBioXcel Therapeutics Hosting Virtual Neuroscience R&D Day..
      12/11/202307:00GLOBEBioXcel Therapeutics Strengthens Clinical Development..
      12/06/202307:00EDGAR2Form 8-K - Current report
      11/30/202307:00GLOBEBioXcel Therapeutics to Host Virtual Neuroscience R&D Day on..
      11/13/202311:59EDGAR2Form RW WD - Withdrawal of Registration Withdrawal Request
      11/13/202310:23EDGAR2Form RW - Registration Withdrawal Request
      11/08/202307:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
      11/06/202307:00GLOBEBioXcel Therapeutics Announces Update on NIDA-funded Trial..
      11/02/202306:01EDGAR2Form S-3 - Registration statement under Securities Act of..
      10/31/202307:00GLOBEBioXcel Therapeutics to Report Third Quarter 2023 Financial..
      10/30/202307:00GLOBEBioXcel Therapeutics Receives Permanent J-Code for IGALMI™..
      10/25/202310:30APSStrong Open For Biotech Shares Following Phase 3 Comments
      10/25/202307:00GLOBEBioXcel Therapeutics Announces Positive Findings from..
      10/19/202316:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      10/10/202307:06EDGAR2Form 8-K - Current report
      10/10/202307:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
      10/04/202307:05EDGAR2Form 8-K - Current report
      10/04/202307:00GLOBEBioXcel Therapeutics Provides Update on Recent Developments..
      9/25/202317:07EDGAR2Form 8-K - Current report
      9/20/202311:21EDGAR2Form 144 - Report of proposed sale of securities
      9/20/202311:15EDGAR2Form 144 - Report of proposed sale of securities
      9/19/202308:00EDGAR2Form 8-K - Current report
      9/18/202316:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/18/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/18/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      BTAI
      BioXcel Therapeutics
      Delayed Upgrade Clock